Next Article in Journal
Extracts of Sideritis scardica and Clinopodium vulgare Alleviate Cognitive Impairments in Scopolamine-Induced Rat Dementia
Next Article in Special Issue
Exploring Individual Variability in Drug-Induced Liver Injury (DILI) Responses through Metabolomic Analysis
Previous Article in Journal
Elevated Arterial Blood Pressure as a Delayed Complication Following COVID-19—A Narrative Review
Previous Article in Special Issue
Effects of Waterpipe Smoke Exposure on Experimentally Induced Chronic Kidney Disease in Mice
 
 
Article
Peer-Review Record

Investigation of Gastrointestinal Toxicities Associated with Concurrent Abdominal Radiation Therapy and the Tyrosine Kinase Inhibitor Sunitinib in a Mouse Model

Int. J. Mol. Sci. 2024, 25(3), 1838; https://doi.org/10.3390/ijms25031838
by Amber R. Prebble 1, Bailey Latka 2, Braden Burdekin 2, Del Leary 3, Mac Harris 4, Daniel Regan 4 and Mary-Keara Boss 2,*
Reviewer 1:
Reviewer 2:
Int. J. Mol. Sci. 2024, 25(3), 1838; https://doi.org/10.3390/ijms25031838
Submission received: 22 December 2023 / Revised: 26 January 2024 / Accepted: 30 January 2024 / Published: 2 February 2024
(This article belongs to the Collection Feature Papers in Molecular Toxicology)

Round 1

Reviewer 1 Report

Comments and Suggestions for Authors

1.The author should further explain the novelty of this study. Line 332-Lin335 indicated that previous studies reported the post-RT GI vascularization and inflammation. In this study sunitinib seemed not to induce inflammation and authors should further elaborate their new discoveries in this study.

2. Figure 4 crypt area for each treatment group should be pointed out by arrows and further zoomed

3 Figure 5 histological figures (such as sample tissues under microscope) should be provided 

4 Figure 6 two set of bar graphs should be given  one for SI villi, another for LI crypts 

 

Author Response

Please see the attachment.

Author Response File: Author Response.pdf

Reviewer 2 Report

Comments and Suggestions for Authors

The manuscript is devoted to the gastrointestinal toxicity of combined cancer therapy with ionizing radiation and a tyrosine kinase inhibitor (sunitinib) in a mouse model. The authors identified a lack of angiogenic response in irradiated gastrointestinal tissues when abdominal radiation treatment was combined with sunitinib, which may correlate with clinical toxicities seen in canine and human patients receiving combined treatment.

The manuscript is neatly written, with a good introduction and discussion, methods and results properly presented. My main doubt concerns the suitability of the manuscript for the journal. In my opinion it should be submitted rather to an oncologic journal, its contribution to the molecular sciences being secondary and concerning the effect of sunitinib at the organismal level in combined cancer therapy.

Minor remarks:

Figures 1,3,6, and 7. As the magnification depends on the magnification of the picture, could the Authors consider placing a dimension bar (e. g. 100 um) on the photo?

Figure 5. Smaller inscriptions are hardly visible, so some magnification of the Figure or increase the font would be advisable.

Line 498: “sectioned at 5 mM”?

Author Response

Please see the attachment.

Author Response File: Author Response.pdf

Round 2

Reviewer 1 Report

Comments and Suggestions for Authors

The author has revised the manuscript properly according to reviewer's comments .

Back to TopTop